A Study to Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy Volunteers

NCT02512562 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: AL-335
DRUG: ACH-3102
DRUG: Simeprevir

Sponsor

Alios Biopharma Inc.

Collaborators

[object Object]